Rheumatological evaluation of the patient with interstitial lung disease

##plugins.themes.bootstrap3.article.sidebar##

PDF (Español (España)) Crossref (Español (España))
Published Jan 9, 2020

##plugins.themes.bootstrap3.article.main##

Verónica Wolff C.
Hospital del Salvador. Instituto Nacional del Tórax. Profesor Asistente de la Universidad de Chile. Clínica Las C ondes. Santiago
Omar Valenzuela L.
Hospital Padre Hurtado. Clínica Alemana de Santiago. Universidad del Desarrollo. Santiago

Abstract

Connective Tissue Diseases (CTD) comprise a heterogeneous group of multisystemic pathologies of autoimmune origin. Interstitial lung disease (ILD) associated with CTD (CTD-ILD) is common and and it worsens the prognosis of CTD. CTD-ILD represent approximately 15-30% of the universe of ILD and have the same histopathological and radiological forms described for idiopathic ILD. This highlights the importance of routinely incorporate a rheumatologist into the multidisciplinary committee for the diagnosis and management of ILD.

##plugins.themes.bootstrap3.article.details##

Keywords.

Lung Diseases, Interstitial, Connective Tissue Diseases, Rheumatologists

Issue
Vol. 35 No. 4 (2019): Chilean clinical practice guidelines for idiopathic pulmonary fibrosis, 2019
Section
Artícules
Copyright.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Wolff C., V., & Valenzuela L., O. (2020). Rheumatological evaluation of the patient with interstitial lung disease. Revista Chilena De Enfermedades Respiratorias, 35(4), 278–281. Retrieved from https://revchilenfermrespir.cl/index.php/RChER/article/view/858